[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Optibiotix Health PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Optibiotix Health PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Circassia Pharmaceuticals plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Circassia Pharmaceuticals plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

C4X Discovery Holdings PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

C4X Discovery Holdings PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Horizon Discovery Group PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Horizon Discovery Group PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bioventix PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioventix PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Midatech Pharma PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Midatech Pharma PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Shield Therapeutics PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Shield Therapeutics PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Venture Life Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venture Life Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

IXICO plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

IXICO plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Collagen Solutions plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Collagen Solutions plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Science in Sport plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Science in Sport plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Oryzon Genomics SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oryzon Genomics SA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Laboratorio Reig Jofre SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorio Reig Jofre SA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Pharma Mar SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharma Mar SA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

1nkemia IUCT Group SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

1nkemia IUCT Group SA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Otcpharm Pao Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Otcpharm Pao Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Applied Genetic Technologies Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Applied Genetic Technologies Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Amphastar Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amphastar Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Merrimack Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merrimack Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Voyager Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Voyager Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Medpace Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medpace Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Xencor Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xencor Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aeglea Bio Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aeglea Bio Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bluebird bio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bluebird bio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

PRA Health Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PRA Health Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Selecta Biosciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Selecta Biosciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Revance Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Revance Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Soleno Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Soleno Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Egalet Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Egalet Corp Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Intracellular Th Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intracellular Th Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Prothena Corporation plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Prothena Corporation plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Cancer Genetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cancer Genetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Jaguar Health Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jaguar Health Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Reata Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reata Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Regulus Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regulus Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Affimed NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affimed NV Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Otonomy Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Otonomy Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

PTC Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PTC Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Acceleron Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acceleron Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Adverum Biotechnologies Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adverum Biotechnologies Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

IVERIC bio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

IVERIC bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Pieris Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pieris Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ultragenyx Pharmaceutical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ultragenyx Pharmaceutical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

DarioHealth Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

DarioHealth Corp Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Flex Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Flex Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Fortress Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Fortress Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

NantKwest Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NantKwest Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Caredx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caredx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Crispr Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Crispr Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Foamix Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Foamix Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers